Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.25 is 26% below its 5-year average of -0.20, around the middle of its 5-year range (-0.35–-0.02).
15.25% above its 12-month average of -0.29.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.05.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 14 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.25
EARNINGS PER SHARE (EPS) AVG TTM
-0.29
EARNINGS PER SHARE (EPS) AVG 3Y
-0.28
EARNINGS PER SHARE (EPS) AVG 5Y
-0.20
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+15.25%
CURRENT VS 3Y AVG
+10.71%
CURRENT VS 5Y AVG
-26.19%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Estrella Immunopharma, Inc.
Market Cap
$18.77M
Earnings Per Share (EPS)
-0.25
TTM Avg
-0.29
3Y Avg
-0.28
5Y Avg
-0.20
Market Cap
$18.82M
Earnings Per Share (EPS)
-0.66
TTM Avg
-0.90
3Y Avg
-9.28
5Y Avg
-9.88
Market Cap
$20.93M
Earnings Per Share (EPS)
-0.89
TTM Avg
-2.16
3Y Avg
-1.83
5Y Avg
-1.83
Market Cap
$16.58M
Earnings Per Share (EPS)
-3.73
TTM Avg
-46.49
3Y Avg
-194.14
5Y Avg
-195.03
Market Cap
$16.54M
Earnings Per Share (EPS)
-0.21
TTM Avg
-0.22
3Y Avg
-0.25
5Y Avg
-0.30
Market Cap
$16.22M
Earnings Per Share (EPS)
-0.76
TTM Avg
-2.06
3Y Avg
-5.59
5Y Avg
-9.29
Market Cap
$15.91M
Earnings Per Share (EPS)
-0.78
TTM Avg
-8.29
3Y Avg
-9461.74
5Y Avg
-302593.36
Market Cap
$21.90M
Earnings Per Share (EPS)
-1.66
TTM Avg
-1.66
3Y Avg
-2.82
5Y Avg
-25.82
Market Cap
$15.30M
Earnings Per Share (EPS)
-0.77
TTM Avg
-1.25
3Y Avg
-1.82
5Y Avg
-1.86
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | $18.77M | -0.25 | -0.29 | -0.28 | -0.20 |
| Cosmos Health Inc. (COSM)vs › | $18.82M | -0.66 | -0.90 | -9.28 | -9.88 |
| Actuate Therapeutics Inc (ACTU)vs › | $20.93M | -0.89 | -2.16 | -1.83 | -1.83 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.58M | -3.73 | -46.49 | -194.14 | -195.03 |
| Dyadic International, Inc. (DYAI)vs › | $16.54M | -0.21 | -0.22 | -0.25 | -0.30 |
| BioCardia, Inc. (BCDA)vs › | $16.22M | -0.76 | -2.06 | -5.59 | -9.29 |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.91M | -0.78 | -8.29 | -9461.74 | -302593.36 |
| Aytu BioPharma, Inc. (AYTU)vs › | $21.90M | -1.66 | -1.66 | -2.82 | -25.82 |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -0.77 | -1.25 | -1.82 | -1.86 |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -2.11 | -3.38 | -4.90 | -6.31 |
Trailing EPS (TTM)
$-0.25
Forward EPS (Est.)
$-0.25
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.35 |
| 2024-12-31 | -0.24 |
| 2024-06-30 | -0.21 |
| 2022-12-31 | -0.32 |
| 2022-06-30 | -0.05 |
| 2021-06-30 | -0.02 |
